Comparative covalent protein binding of 2,5-Hexanedione and 3-Acetyl-2,5-Hexanedione in the rat

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 14, 2009, Pages 861-869

  DeCaprio, Anthony P ^a,b,d   Kinney, Elizabeth A ^b   Lopachin, Richard M ^c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5-HEXANEDIONE; 3 ACETYL 2,5 HEXANEDIONE; 3-ACETYL-2,5-HEXANEDIONE; ACETONYLACETONE; ALKANONE; CYTOSKELETON PROTEIN; DRUG DERIVATIVE; ERGOSTEROL; HEXANE; N-HEXANE; PORTENSTEROL;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; MALE; METABOLISM; NERVE FIBER; RAT; SPINAL CORD; TOXICITY AND INTOXICATION; WISTAR RAT;

ANIMALS; AXONS; CYTOSKELETAL PROTEINS; ERGOSTEROL; HEXANES; HEXANONES; MALE; MOLECULAR STRUCTURE; NEUROTOXICITY SYNDROMES; RATS; RATS, WISTAR; SPINAL CORD;

EID: 67650287665     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390902959508     Document Type: Article

References (46)

1. Abou-Donia, M. B. 1978. Role of acid phosphatase in delayed neurotoxicity induced by leptophos in hens. Biochem. Pharmacol. 27:2055-2058. (Pubitemid 9043859)
2. Alexander, R. S. and Butler, A. R. 1976. Electrophilic substitution in pyrroles. Part 1. Reaction with 4-dimethylaminobenzaldehyde (Ehrlich's reagent) in acid solution. J. Chem. Soc. Perkin Trans. II:696-701.
3. Amarnath, V., Valentine, W. M., Amarnath, K., Eng, M. A., and Graham, D. G. 1994. The mechanism of nucleophilic substitution of alkylpyrroles in the presence of oxygen. Chem. Res. Toxicol. 7:56-61. (Pubitemid 24041603)
4. Anthony, D. C., Boekelheide, K., Anderson, C. W., and Graham, D. G. 1983. The effect of 3, 4-dimethyl substitution on the neurotoxicity of 2, 5-hexanedione. II. Dimethyl substitution accelerates pyrrole formation and protein crosslinking. Toxicol. Appl. Pharmacol. 71:372-382. (Pubitemid 14218619)
5. Boya, M., Marquet, J., Moreno-Mañas, M., and Prior, M. 1979. Metal complexes in organic synthesis. III. Preparation of 3-alkylpentane-2, 4-diones by alkylation of nickel bis-pentane-2, 4-dionato with alkyl halides. Anal. Quim. 75:920-926.
6. Chiu, F.-C. and Norton, W. T. 1982. Bulk preparation of CNS cytoskeleton and the separation of individual neurofilament by gel filtration: Dyebinding characteristics and amino acid compositions. J. Neurochem. 39:1252-1260. (Pubitemid 13220378)
7. DeCaprio, A. P. 1986. Mechanisms of in vitro pyrrole adduct autoxidation in 2, 5-hexanedione-treated protein. Mol. Pharmacol. 30:452-458. (Pubitemid 17202423)
8. DeCaprio, A. P. 2000. n-Hexane, metabolites, and derivatives. In Experimental and Clinical Neurotoxicology, eds. P. S. Spencer, H. H. Schaumburg, and C. Ludolph, pp. 633-648. New York: Oxford University Press.
9. DeCaprio, A. P., Briggs, R. G., Jackowski, S. J., and Kim, J. C. S. 1988. Comparative neurotoxicity and pyrrole-forming potential of 2, 5-hexanedioneand perdeuterio-2, 5-hexanedione in the rat. Toxicol. Appl. Pharmacol. 92:75-85. (Pubitemid 18049692)
10. DeCaprio, A. P. and Fowke, J. H. 1992. Limited and selective adduction of carboxyl-terminal lysines in the high molecular weight neurofilament proteins by 2, 5-hexanedione in vitro. Brain Res. 586:219-228.
11. DeCaprio, A. P., Jackowski, S. J., and Regan, K. A. 1987. Mechanism of formation and quantitation of imines, pyrroles, and stable nonpyrrole adducts in 2, 5-hexanedione-treated protein. Mol. Pharmacol. 32:542-548. (Pubitemid 18006157)
12. DeCaprio, A. P., Kinney, E. A., and Fowke, J. H. 1997. Regioselective binding of 2, 5-hexanedione to high-molecular-weight rat neurofilament proteins in vitro. Toxicol. Appl. Pharmacol. 145:211-217. (Pubitemid 27294785)
13. DeCaprio, A. P., and O'Neill, E. A. 1985. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2, 5-hexanedione exposure. Toxicol. Appl. Pharmacol. 78:235-247. (Pubitemid 15081083)
14. DeCaprio, A. P., Olajos, E. J., and Weber, P. 1982. Covalent binding of a neurotoxic n-hexane metabolite: Conversion of primary amines to substituted pyrrole derivatives by 2, 5-hexanedione. Toxicol. Appl. Pharmacol. 65:440-450. (Pubitemid 13223253)
15. Derelanko, M. J. 1987. Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H] diisopropylfluorophosphate ([3H]DFP) method. Toxicol. Sci. 9:271-276.
16. deSousa, B. N., and Horrocks, L. P. 1979. Development of rat spinal cord. I. Weight and length with a method for rapid removal. Dev. Neurosci. 2:115-121.
17. Fedtke, N., and Bolt, H. M. 1987. 4, 5-Dihydroxy-2-hexanone: A new metabolite of n-hexane and of 2, 5-hexanedione in rat urine. Biomed. Environ. Mass Spectrom. 14:563-572. (Pubitemid 18060764)
18. Fletcher, H. 1966. 1, 3, 4, 7-Substituted isoindoles and isoindolenines. Tetrahedron 22:2481-2486.
19. Gardini, G. P. 1973. The oxidation of monocyclic pyrroles. Adv. Heterocyclic Chem. 15:67-98.
20. Genter St.Clair, M. B., Amarnath, V., Moody, M. A., Anthony, D. C., Anderson, C. W., and Graham, D. G. 1988. Pyrrole oxidation and protein cross-linking as necessary steps in the development of ?-diketone neuropathy. Chem. Res. Toxicol. 1:179-185.
21. Genter, M. B., Szakál-Quin, G., Anderson, W., Anthony, D. C., and Graham, D. G. 1986. Evidence that pyrrole formation is a pathogenetic step in ?-diketone neuropathy. Toxicol. Appl. Pharmacol. 87:351-362. (Pubitemid 17019119)
22. Graham, D. G., Anthony, D. C., Boekelheide, K., Maschmann, N. A., Richards, R. G., Wolfram, J. W., and Shaw, B. R. 1982. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. Toxicol. Appl. Pharmacol. 64:415-422. (Pubitemid 12019093)
23. Graham, D. G., Genter St.Clair, M. B., Amarnath, V., and Anthony, D. C. 1991. Molecular mechanisms of ?-diketone neuropathy. Adv. Exp. Med. Biol. 283:427-431.
24. Helfand, B. T., Chang, L., and Goldman, R. D. 2003. The dynamic and motile properties of intermediate filaments. Ann. Rev. Cell Dev. Biol. 19:445-467. (Pubitemid 37487356)
25. Krasavage, W. J., O'Donoghue, J. L., DiVincenzo, G. D., and Terhaar, C. J. 1980. The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol. Appl. Pharmacol. 52:433-441. (Pubitemid 10135390)
26. Lehning, E. J., Jortner, B. S., Fox, J. H., Arezzo, J. C., Kitano, T.-A., and LoPachin, R. M. 2000. γ-Diketone peripheral neuropathy I. Quantitative morphometric analyses of axonal atrophy and swelling. Toxicol. Appl. Pharmacol. 165:127-140. (Pubitemid 30395362)
27. LoPachin, R. M. and DeCaprio, A. P. 2004. γ-Diketone neuropathy: Axon atrophy and the role of cytoskeletal protein adduction. Toxicol. Appl. Pharmacol. 199:20-34. (Pubitemid 39099452)
28. LoPachin, R. M. and DeCaprio, A. P. 2005. Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol. Sci. 86:214-225. (Pubitemid 41418633)
29. LoPachin, R. M., He, D., and Reid, M. L. 2005. 2, 5-Hexanedione-induced changes in the neurofilament subunit pools of rat peripheral nerve. NeuroToxicology 26:229-240. (Pubitemid 40248441)
30. LoPachin, R. M., He, D., Reid, M. L., and Opanashuk, L. A. 2004. 2, 5- Hexanedione-induced changes in the monomeric neurofilament protein content of rat spinal cord fractions. Toxicol. Appl. Pharmacol. 198:61-73. (Pubitemid 38789129)
31. LoPachin, R. M., Jortner, B. S., Reid, M. L., and Das, S. 2003. γ-Diketone central neuropathy: Quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots. Toxicol. Appl. Pharmacol. 193:29-46. (Pubitemid 37373763)
32. LoPachin, R. M., Ross, J. F., Reid, M. L., Das, S., Mansukhani, S., and Lehning, E. J. 2002. Neurological evaluation of toxic axonopathies in rats: Acrylamide and 2, 5-hexanedione. NeuroToxicology 23:95-110. (Pubitemid 36559702)
33. Monaco, S., Wongmongkolrit, T., Shearson, C. M., Patton, A., Schaetzle, B., Autilio-Gambetti, L., Gambetti, P., and Sayre, L. M. 1990. Giant axonopathy characterized by intermediate location of axonal enlargements and acceleration of neurofilament transport. Brain Res. 519:73-81. (Pubitemid 20199672)
34. Pyle, S. J., Amarnath, V., Graham, D. G., and Anthony, D. C. 1992. The role of pyrrole formation in the alteration of neurofilament transport induced during exposure to 2, 5-hexanedione. J. Neuropathol. Exp. Neurol. 51:451-458.
35. Rosenberg, C. K., Genter, M. B., Szakal-Quin, G., Anthony, D. C., and Graham, D. G. 1986. dl- Versus meso-3, 4-Dimethyl-2, 5-hexanedione: A morphometric study of the proximo-distal distribution of axonal swellings in the anterior root of the rat. Toxicol. Appl. Pharmacol. 87:363-373. (Pubitemid 17019120)
36. Shea, T. B., Jung, C., Yabe, J., Ma, D., and Fischer, I. 1998 Extensive phosphorylation and axonal transport of triton-soluble neurofilament subunits. In Sub-cellular Biochemistry, vol. 31, Intermediate Filaments, eds. H. D. Herrmann and R. A. Harris, pp. 527-561. New York: Plenum Press.
37. Spencer, P. S., Bischoff, M. C., and Schaumburg, H. H. 1978. On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral distal axonopathy. Toxicol. App. Pharmacol. 44:17-28. (Pubitemid 8381299)
38. Spencer, P. S., Schaumburg, H. H., Sabri, M. I., and Veronesi, B. 1980. The enlarging view of hexacarbon neurotoxicity. CRC Crit. Rev. Toxicol. 7:279-356.
39. Stone, J. D., Peterson, A. P., Eyer, J., Oblak, T. G., and Sickles, D. W. 1999. Axonal neurofilaments are nonessential elements of toxicant-induced reductions in fast axonal transport: Video-enhanced differential interference microscopy in peripheral nervous system axons. Toxicol. Appl. Pharmacol. 161:50-58.
40. Stone, J. D., Peterson, A. P., Eyer, J., Oblak, T. G., and Sickles, D. W. 2001. Neurofilaments are nonessential to the pathogenesis of toxicant-induced axonal degeneration. J. Neurosci. 21:2278-2287. (Pubitemid 32240526)
41. Stone, J. D., Peterson, A. P., Eyer, J., and Sickles, D. W. 2000. Neurofilaments are non-essential elements of toxicant-induced reductions in fast axonal transport: Pulse labeling in CNS neurons. NeuroToxicology 21:447-457.
42. Wang, Q. S., Hou, L. Y., Zhang, C. L., Song, F. Y., and Xie, K. Q. 2008. Changes of cytoskeletal proteins in nerve tissues and serum of rats treated with 2, 5-hexanedione. Toxicology 244:166-178.
43. Xu, G. Z., Singh, M. P., Gopal, D., and Sayre, L. M. 2001. Novel 2, 5- hexanedione analogues. Substituent-induced control of the protein crosslinking potential and oxidation susceptibility of the resulting primary amine-derived pyrroles. Chem. Res. Toxicol. 14:264-274. (Pubitemid 32238486)
44. Yu, R. C., Hattis, D., Landaw, E. M., and Froines, J. R. 2002. Toxicokinetic interaction of 2, 5-hexanedione and methyl ethyl ketone. Arch. Toxicol. 75:643-652. (Pubitemid 34151151)
45. Zhu, M., Spink, D. C., Yan, B., Bank, S., and DeCaprio, A. P. 1994. Formation and structure of crosslinking and monomeric pyrrole autoxidation products in 2, 5-hexanedione-treated amino acids, peptides, and protein. Chem. Res. Toxicol. 7:551-558. (Pubitemid 24232353)
46. Zhu, M., Spink, D. C., Yan, B., Bank, S., and DeCaprio, A. P. 1995. Inhibition of 2, 5-hexanedione-induced covalent protein crosslinking by biological thiols: Chemical mechanisms and toxicological implications. Chem. Res. Toxicol. 8:764-771.